No Data
Zhengye Biotechnology | 6-K: Report of foreign private issuer (related to financial reporting)
Zhengye Biotechnology Holding Limited (NASDAQ:ZYBT) May Have Run Too Fast Too Soon With Recent 26% Price Plummet
Central U.S. Manufacturing Activity Increases at Faster Pace -- Kansas City Fed
Express News | Form 144 | Zhengye Biotechnology(ZYBT.US) Insider Proposes to Sell 29.42 Million in Common Stocks
Risks Still Elevated At These Prices As Zhengye Biotechnology Holding Limited (NASDAQ:ZYBT) Shares Dive 79%
U.S. to Honor 15% Tariff Rate on EU Pharmaceuticals, Official Says -- WSJ